ARTYKUŁ PRZEGLĄDOWY
TGF-β1 i elastaza granulocytów w ocenie aktywności nieswoistych chorób zapalnych jelit. Badanie pilotażowe
Irena Ciećko-Michalska 1 , Iga Wierzbicka-Tutka 2 , Małgorzata Szczepanek 1 , Danuta Fedak 3 , Konrad Jabłoński 1 , Dorota Cibor 1 , Tomasz Mach 11. Department of Gastroenterology, Hepatology and Infectious Diseases, Jagiellonian University Medical College, Cracow, Poland
2. Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital, Cracow, Poland
3. Department of Clinical Biochemistry, Jagiellonian University Medical College, Cracow, Poland
Opublikowany: 2014-01-23
DOI: 10.5604/17322693.1086361
GICID: 01.3001.0003.1180
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2014; 68 : 66-72
Abstrakt
Przypisy
- 1. Andus T., Gross V., Caesar I., Krumm D., Hosp J., Gerok W., ScholmerichJ.: PMN-elastase in assessment of patients with inflammatorybowel disease. Dig. Dis. Sci., 1993; 38: 1638-1644
Google Scholar - 2. Babyatsky M.W., Rossiter G., Podolsky D.K.: Expression of transforminggrowth factors alpha and beta in colonic mucosa in inflammatorybowel disease. Gastroenterology, 1996; 110: 975-984
Google Scholar - 3. Bosani M., Ardizzone S., Porro G.B.: Biologic targeting in thetreatment of inflammatory bowel diseases. Biologics, 2009; 3: 77-97
Google Scholar - 4. Fischbach W., Becker W., Mossner J., Ohlemuller H., Koch W.,Borner W.: Leucocyte elastase in chronic inflammatory bowel diseases:a marker of inflammatory activity? Digestion, 1987; 37: 88-95
Google Scholar - 5. Gouni-Berthold I., Baumeister B., Wegel E., Berthold H.K., VetterH., Schmidt C.: Neutrophil-elastase in chronic inflammatory boweldisease: a marker of disease activity? Hepatogastroenterology, 1999;46: 2315-2320
Google Scholar - 6. Kader H.A., Tchernev V.T., Satyaraj E., Lejnine S., Kotler G., KingsmoreS.F., Patel D.D.: Protein microarray analysis of disease activityin pediatric inflammatory bowel disease demonstrates elevated serumPLGF, IL-7, TGF-β1, and IL-12p40 levels in Crohn’s disease andulcerative colitis patients in remission versus active disease. Am. J.Gastroenterol., 2005; 100: 414-423
Google Scholar - 7. Kanazawa S., Tsunoda T., Onuma E., Majami T., Kagiyama M., KikuchiK.: VEGF, basic-FGF, and TGF-β in Crohn›s disease and ulcerativecolitis: a novel mechanism of chronic intestinal inflammation. Am.J. Gastroenterol., 2001; 96: 822-828
Google Scholar - 8. Kiliç Z.M., Ayaz S., Ozin Y., Nadir I., Cakal B., Ulker A.: Plasmatransforming growth factor-β1 level in inflammatory bowel disease.Turk. J. Gastroenterol., 2009; 20: 165-170
Google Scholar - 9. Langhorst J., Elsenbruch S., Koelzer J., Rueffer A., Michalsen A.,Dobos G.: Noninvasive markers in the assessment of intestinal inflammationin inflammatory bowel diseases: performance of fecallactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.Am. J. Gastroenterol., 2008; 103: 162-169
Google Scholar - 10. Niessner M., Volk B.A.: Altered Th1/Th2 cytokine profiles inthe intestinal mucosa of patients with inflammatory bowel diseaseas assessed by quantitative reversed transcribed polymerase chainreaction (RT-PCR). Clin. Exp. Immunol., 1995; 101: 428-435
Google Scholar - 11. Shah N., Kammermeier J., Elawad M., Glocker E.O.: Interleukin-10and interleukin-10-receptor defects in inflammatory bowel disease.Curr. Allergy Asthma Rep., 2012; 12: 373-379
Google Scholar - 12. Sipos F., Galamb O.: Epithelial-to mesenchymal and mesenchymal-to-epithelialtransitions in the colon. World J. Gastroenterol.,2012: 18: 601-608
Google Scholar - 13. Wedrychowicz A., Kowalska-Duplaga K., Jedynak-Wasowicz U.,Pieczarkowski S., Sladek M., Tomasik P., Fyderek K.: Serum concentrationsof VEGF and TGF-β1 during exclusive enteral nutrition inIBD. J. Pediatr. Gastroenterol. Nutr., 2011; 53: 150-155
Google Scholar